Pharmaceutical Articles View all

Pharmaceutical News View all

Pharma Interests View all

Diseases and Health Tips View all

Global Events View all

Dermatology Conference 2018

“International Conference on Clinical & Experimental Dermatology” going to be held during December 05-06,2018 at Dubai,UAE. The conference is organized … Keep Reading

Recent Articles

DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers

in Pharmaceutical News
DuPont Nutrition & Health Helps to Reduce Health Risks forOverweight Consumers

DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at risk of health complications. Combining the benefits of a proven probiotic with a prebiotic fiber, HOWARU® Shape has proven potential to improve metabolic health while supporting weight loss. In a previously published clinical study, a trial group that received HOWARU® Shape had 4.5 percent less total body fat and 6.7 percent less trunk fat than those…

Keep Reading

NEWS RELEASE: CPhI report forecasts India to have strongest global growth in 2019

in Pharmaceutical News
NEWS RELEASE: CPhI report forecasts India to have strongest global growth in 2019

CPhI & P-MEC India – organised by UBM (part of Informa plc) – is set to open its doors to more than 40,000 attendees from 120+ countries and 1500 exhibitors, as new analysis shows a massive improvement in India’s global reputation. The India specific findings of the CPhI Annual Report highlight that India has seen significant jump across all (six) categories, improving its overall score by a massive 11.06% in a single year. The country showed the largest gains in…

Keep Reading

Press release: New study demonstrates significant difference between iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled, randomized clinical investigation

in Pharmaceutical News
Press release: New study demonstrates significant difference between iron isomaltoside and ferric carboxymaltose on hypophosphatemic effects in a controlled, randomized clinical investigation

Results of a study comparing the incidence of hypophosphatemia after high dose IV iron substitution have been presented at the 60th annual meeting of the American Society of Hematology. The HOMe aFers trial recruited women with gynaecological bleeding and subsequent iron deficiency. All subjects were given high dose intravenous iron, randomised between iron isomaltoside and ferric carboxymaltose to correct their iron deficiency. It has been reported[1] that ferric carboxymaltose has a propensity to induce hypophosphatemia. This independent study was conducted…

Keep Reading

1 2 3 114
Go to Top